Abstract
Purpose of reviewThis is a review of the most up-To-date research on the effectiveness of omega-3 fatty acids for reducing the risk of prematurity in well nourished women with access to high-quality obstetric care. It will provide an overview of the translation of the evidence on omega-3 screening into policy, and the latest research on how to implement the policy into practice.Recent findingsFindings of the included clinical studies support that omega-3 supplementation for women with a singleton pregnancy who have a low omega-3 status reduces the risk of early preterm birth.SummaryThere is evidence that screening and providing appropriate advice to women with a singleton pregnancy who have a low omega-3 status can reduce their risk of early preterm birth, and avoiding supplementation for women who are replete will avoid unnecessary supplementation and potential harm.
Original language | English |
---|---|
Pages (from-to) | 81-85 |
Number of pages | 5 |
Journal | Current Opinion in Clinical Nutrition and Metabolic Care |
Volume | 25 |
Issue number | 2 |
DOIs | |
Publication status | Published or Issued - 1 Mar 2022 |
Keywords
- blood fraction
- docosahexaenoic acid
- early preterm birth
- eicosapentaenoic acid
- pregnancy
- prematurity
- total omega-3 fatty acids
ASJC Scopus subject areas
- Nutrition and Dietetics
- Medicine (miscellaneous)